American International Group, Inc. Ocugen, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.82 - $1.33 $1,710 - $2,774	2,086 Added 2.03%	104,850 $89,000
Q4 2022 Feb 10, 2023	BUY	$1.11 - $1.87 $1,272 - $2,143	1,146 Added 1.13%	102,764 $133,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $2,511 - $4,448	1,435 Added 1.43%	101,618 $181,000
Q2 2022 Aug 12, 2022	BUY	$1.83 - $3.45 $15,560 - $29,335	8,503 Added 9.27%	100,183 $227,000
Q1 2022 May 13, 2022	SELL	$2.34 - $4.72 $15,100 - $30,458	-6,453 Reduced 6.58%	91,680 $303,000
Q4 2021 Feb 11, 2022	SELL	$4.38 - $15.67 $12,864 - $46,022	-2,937 Reduced 2.91%	98,133 $447,000
Q3 2021 Nov 12, 2021	SELL	$6.36 - $8.51 $15,270 - $20,432	-2,401 Reduced 2.32%	101,070 $726,000
Q2 2021 Aug 13, 2021	BUY	$5.52 - $15.68 $571,159 - $1.62 Million	103,471 New	103,471 $831,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.